Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
fig.S4.b
Szenker E et al. (2012)
|
Xla Wt + h3f3a MO
NF22 (in situ hybridization)
|
|
|
|
fig.3.d
Zhang X et al. (2012)
|
Xtr Wt + trabd2a MO
NF10.5-11 (in situ hybridization)
|
|
|
|
fig.8.d
Liu C et al. (2012)
|
Xla Wt + map3k7 MO
NF10-10.25 (in situ hybridization)
|
|
|
|
fig.5.c
Belyaeva OV et al. (2012)
|
Xla Wt + sdr16c5
NF32-32 (in situ hybridization)
|
|
|
|
fig.7.a
Belyaeva OV et al. (2012)
|
Xla Wt + sdr16c5 MO
NF20 (in situ hybridization)
|
|
|
|
fig.2.n
Bentaya S et al. (2012)
|
Xla Wt + rbm38
NF20 (in situ hybridization)
|
|
|
|
Fig 4 G
Vandenberg LN et al. (2011)
|
Xla Wt + atp6v0cdel
NF20 (in situ hybridization)
|
|
|
|
Fig 4 H
Vandenberg LN et al. (2011)
|
Xla Wt + atp6v0cdel
NF20 (in situ hybridization)
|
|
|
|
fig.7.c
Rankin SA et al. (2011)
|
Xla Wt + lhx1 + otx2
NF11 (in situ hybridization)
|
|
|
|
fig.7.c
Rankin SA et al. (2011)
|
Xla Wt + sia1
NF11 (in situ hybridization)
|
|
|